Tech Company Financing Transactions
SparingVision Funding Round
On 9/14/2022, SparingVision raised $75 million in Series B funding from JEITO, UPMC Enterprises and 4BIO Capital.
Transaction Overview
Company Name
Announced On
9/14/2022
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors
JEITO (Lead Investor) (Sabine Dandiguian)
UPMC Enterprises (Lead Investor) (Jeanne Cunicelli)
Proceeds Purpose
Proceeds from the financing will be used to fund the first-in-human trials of the Company's two lead gene-independent assets, SPVN06 and SPVN20, as well as the development of genome editing assets through its collaboration with Intellia Therapeutics (NASDAQ: NTLA), a leading clinical-stage genome editing company. The financing extends SparingVision's cash runway to the second half of 2025.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5/7 avenue Percier CS40230
Paris, 75008
FR
Paris, 75008
FR
Phone
Website
Email Address
Overview
SparingVision is a genomic medicines company, translating pioneering science into vision-saving treatments. Founded to advance over 20 years of world-leading ophthalmic research from its scientific founders at the Paris Vision Institute, SparingVision is leading a step shift in how ocular diseases are treated, moving beyond single gene correction therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stanislas Piot
Chief Scientific Officer
Deniz Dalkara
Chief Technical Officer
Rajiv Gangurde
Co-Founder
Thierry Léveillard
Browse more venture capital transactions:
Prev: 9/14/2022: Nile venture capital transaction
Next: 9/14/2022: NYSHEX venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs